BioRender 图标

Human induced pluripotent stem cell 2

Human induced pluripotent stem cell 2 - Editable icon of a jellybean-shaped cell with an ovular nucleus
[{"image":"https://icons.cdn.biorender.com/w75xh75/62165db131012b002910ebd3/62165d4a31012b002910eb9f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/62165db131012b002910ebd3/62165d4a31012b002910eb9f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/62165db131012b002910ebd2/62165d4a31012b002910eb9f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/62165db131012b002910ebd2/62165d4a31012b002910eb9f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/62165db131012b002910ebd1/62165d4a31012b002910eb9f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/62165db131012b002910ebd1/62165d4a31012b002910eb9f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/62165db131012b002910ebd0/62165d4a31012b002910eb9f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/62165db131012b002910ebd0/62165d4a31012b002910eb9f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/62165db131012b002910ebcf/62165d4a31012b002910eb9f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/62165db131012b002910ebcf/62165d4a31012b002910eb9f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/62165db131012b002910ebce/62165d4a31012b002910eb9f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/62165db131012b002910ebce/62165d4a31012b002910eb9f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/62165db131012b002910ebcd/62165d4a31012b002910eb9f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/62165db131012b002910ebcd/62165d4a31012b002910eb9f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/62165db131012b002910ebcc/62165d4a31012b002910eb9f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/62165db131012b002910ebcc/62165d4a31012b002910eb9f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/62165db131012b002910ebcb/62165d4a31012b002910eb9f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/62165db131012b002910ebcb/62165d4a31012b002910eb9f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/62165db131012b002910ebca/62165d4a31012b002910eb9f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/62165db131012b002910ebca/62165d4a31012b002910eb9f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/62165db131012b002910ebc9/62165d4a31012b002910eb9f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/62165db131012b002910ebc9/62165d4a31012b002910eb9f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/62165db131012b002910ebc8/62165d4a31012b002910eb9f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/62165db131012b002910ebc8/62165d4a31012b002910eb9f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/62165db131012b002910ebc7/62165d4a31012b002910eb9f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/62165db131012b002910ebc7/62165d4a31012b002910eb9f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/62165db131012b002910ebc6/62165d4a31012b002910eb9f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/62165db131012b002910ebc6/62165d4a31012b002910eb9f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/62165db131012b002910ebc5/62165d4a31012b002910eb9f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/62165db131012b002910ebc5/62165d4a31012b002910eb9f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/62165db131012b002910ebc4/62165d4a31012b002910eb9f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/62165db131012b002910ebc4/62165d4a31012b002910eb9f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/62165db131012b002910ebc3/62165d4a31012b002910eb9f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/62165db131012b002910ebc3/62165d4a31012b002910eb9f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/62165db131012b002910ebc2/62165d4a31012b002910eb9f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/62165db131012b002910ebc2/62165d4a31012b002910eb9f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/62165db131012b002910ebc1/62165d4a31012b002910eb9f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/62165db131012b002910ebc1/62165d4a31012b002910eb9f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/62165db131012b002910ebc0/62165d4a31012b002910eb9f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/62165db131012b002910ebc0/62165d4a31012b002910eb9f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/62165db131012b002910ebbf/62165d4a31012b002910eb9f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/62165db131012b002910ebbf/62165d4a31012b002910eb9f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/62165db131012b002910ebbe/62165d4a31012b002910eb9f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/62165db131012b002910ebbe/62165d4a31012b002910eb9f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/62165db131012b002910ebbd/62165d4a31012b002910eb9f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/62165db131012b002910ebbd/62165d4a31012b002910eb9f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/62165db131012b002910ebbc/62165d4a31012b002910eb9f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/62165db131012b002910ebbc/62165d4a31012b002910eb9f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/62165db131012b002910ebbb/62165d4a31012b002910eb9f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/62165db131012b002910ebbb/62165d4a31012b002910eb9f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/62165db131012b002910ebba/62165d4a31012b002910eb9f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/62165db131012b002910ebba/62165d4a31012b002910eb9f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/62165db131012b002910ebb9/62165d4a31012b002910eb9f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/62165db131012b002910ebb9/62165d4a31012b002910eb9f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/62165db131012b002910ebb8/62165d4a31012b002910eb9f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/62165db131012b002910ebb8/62165d4a31012b002910eb9f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/62165db131012b002910ebb7/62165d4a31012b002910eb9f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/62165db131012b002910ebb7/62165d4a31012b002910eb9f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/62165db131012b002910ebb6/62165d4a31012b002910eb9f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/62165db131012b002910ebb6/62165d4a31012b002910eb9f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/62165db131012b002910ebb5/62165d4a31012b002910eb9f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/62165db131012b002910ebb5/62165d4a31012b002910eb9f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/62165db131012b002910ebb4/62165d4a31012b002910eb9f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/62165db131012b002910ebb4/62165d4a31012b002910eb9f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/62165db131012b002910ebb3/62165d4a31012b002910eb9f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/62165db131012b002910ebb3/62165d4a31012b002910eb9f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/62165db131012b002910ebb2/62165d4a31012b002910eb9f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/62165db131012b002910ebb2/62165d4a31012b002910eb9f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/62165db131012b002910ebb1/62165d4a31012b002910eb9f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/62165db131012b002910ebb1/62165d4a31012b002910eb9f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/62165db131012b002910ebb0/62165d4a31012b002910eb9f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/62165db131012b002910ebb0/62165d4a31012b002910eb9f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/62165db131012b002910ebaf/62165d4a31012b002910eb9f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/62165db131012b002910ebaf/62165d4a31012b002910eb9f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/62165db131012b002910ebae/62165d4a31012b002910eb9f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/62165db131012b002910ebae/62165d4a31012b002910eb9f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/62165db131012b002910ebad/62165d4a31012b002910eb9f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/62165db131012b002910ebad/62165d4a31012b002910eb9f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/62165db131012b002910ebac/62165d4a31012b002910eb9f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/62165db131012b002910ebac/62165d4a31012b002910eb9f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/62165db131012b002910ebab/62165d4a31012b002910eb9f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/62165db131012b002910ebab/62165d4a31012b002910eb9f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/62165db131012b002910ebaa/62165d4a31012b002910eb9f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/62165db131012b002910ebaa/62165d4a31012b002910eb9f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/62165db131012b002910eba9/62165d4a31012b002910eb9f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/62165db131012b002910eba9/62165d4a31012b002910eb9f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/62165db131012b002910eba8/62165d4a31012b002910eb9f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/62165db131012b002910eba8/62165d4a31012b002910eb9f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/62165db131012b002910eba7/62165d4a31012b002910eb9f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/62165db131012b002910eba7/62165d4a31012b002910eb9f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/62165db131012b002910eba6/62165d4a31012b002910eb9f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/62165db131012b002910eba6/62165d4a31012b002910eb9f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/62165db131012b002910eba5/62165d4a31012b002910eb9f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/62165db131012b002910eba5/62165d4a31012b002910eb9f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/62165db131012b002910eba4/62165d4a31012b002910eb9f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/62165db131012b002910eba4/62165d4a31012b002910eb9f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/62165db131012b002910eba3/62165d4a31012b002910eb9f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/62165db131012b002910eba3/62165d4a31012b002910eb9f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/62165db131012b002910eba2/62165d4a31012b002910eb9f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/62165db131012b002910eba2/62165d4a31012b002910eb9f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/62165db131012b002910eba1/62165d4a31012b002910eb9f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/62165db131012b002910eba1/62165d4a31012b002910eb9f.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/62165db131012b002910eba0/62165d4a31012b002910eb9f.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/62165db131012b002910eba0/62165d4a31012b002910eb9f.png"}]
使用此图标 – 免费
注册无需信用卡。

此图标可在 BioRender 中完全编辑

  • 添加文本、形状及其他图标
  • 搜索 50,000 多种科学准确的图标
  • 重新着色并重新排列每一个图标、线条和标签
  • 导出或分享以满足任何使用需求
Scientist Avatars

加入 400 多万名科学家 的行列,制作可直接用于发表的图表

从图标到成品图表,只需几分钟

  • 搜索 来自 50,000 多个科学准确、经同行评审的图标
  • 自定义 添加标签、形状和更多图标——一切皆可完全编辑
  • 导出 或与协作者分享您的图表
    ‍

图标不合适?探索更多内容。

搜索涵盖 30 多个生命科学领域的 50,000 多个图标。

search icon
arrow-right
hiPSC,iPSC,Human induced pluripotent stem cell,human induced,pluripotent,stem cell,cell,stem,stem cell,progenitor cell,progenitor,differentiation, hsc,hematopoietic stem cell,hiPSC,iPSC
查看更多

尝试使用同义词,或注册以在应用中请求图标。

图像类型

Human induced pluripotent stem cell 2 icon JPEG

Human induced pluripotent stem cell 2 icon PNG

Human induced pluripotent stem cell 2 icon SVG

Human induced pluripotent stem cell 2 icon GIF

BioRender 图标常见问题解答

How are scientists using the Human induced pluripotent stem cell 2 icon in their work?

BioRender users often use the Human induced pluripotent stem cell 2 icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Cell Types.

我可以在 BioRender 图表或科学插图中使用此图标吗?

Yes, the Human induced pluripotent stem cell 2 is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the Human induced pluripotent stem cell 2 icon customizable in BioRender?

Most icons in BioRender, including the Human induced pluripotent stem cell 2 icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

Can I export figures that include the Human induced pluripotent stem cell 2 icon for publication or presentations?

Yes, figures containing the Human induced pluripotent stem cell 2 icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

How do I cite BioRender if I use this icon?

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Is the Human induced pluripotent stem cell 2 icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the Human induced pluripotent stem cell 2 icon — especially those focused on Cell Types. You can search BioRender’s template library or add this icon manually to any canvas.

什么是 BioRender?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Human induced pluripotent stem cell 2 icon along with our library of more than 30,000 life science icons.

在 BioRender 中使用此图标

立即开始制作专业的科学图表
antibody elements3D Phospholipid illustration

正在寻找科学内容?

浏览超过 5 万个经同行评审、易于使用且免费的图标和模板。

立即寻找您的专属素材
x icon